课题基金 / 基金详情

The role of allelic expression imbalance (AER) in interindividual differences in CYP3A4 activity and it's clinical implications.

The role of allelic expression imbalance (AER) in interindividual differences in CYP3A4 activity and it's clinical implications.
等位基因表达失衡 (AER) 在 CYP3A4 活性个体差异中的作用及其临床意义。
批准号:
17390043
负责人:
IEIRI Ichiro
金额:
$9.64万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

IEIRI Ichiro的其他基金

相似基金

相关文献

中文摘要
翻译
(1)等位基因表达率(AER)常规检测试剂盒的研制以人CYP 3A 4基因第88742位的单核苷酸多态性(SNP)T/T缺失为标志物,用DNA系列稀释标准样品(即,每个等位基因纯合)用于校准等位基因比率和荧光强度之间的相关性(维克/ FAM)检测结果良好。(2)临床应用使用该检测试剂盒,我们在日本健康志愿者中评价了个体AER与咪达唑仑和伊曲康唑代谢活性之间的关系。不幸的是,由于样本量小,未观察到明确的关系。由于成功估计了个体AER,因此需要使用更特异的CYP 3A 4底物药物进行更大样本量的研究。(3)甲基化分析印迹控制中心(ICR)内存在多个CpG岛,ICR位于人CYP 3A 4基因的上游。对82363 - 82893位的4个CG位点进行甲基化分析,发现第14和16位CG位点的甲基化频率与CYP 3A 4 mRNA表达水平呈显著负相关。(4)选择CYP 3A 4基因的5 '上游和3'下游区域、5 '-UTR和启动子区域作为靶点。在不同靶点区域观察到抗Ac-H3结合能力的较大个体间差异,CYP 3A 4基因5'上游区域的组蛋白乙酰化与mRNA表达显著相关。(5)上述4个CG位点的甲基化频率与CYP 3A 4基因上游约2000 bp处的组蛋白乙酰化水平显著相关。这些结果表明,ICR中DNA甲基化参与了CYP 3A 4基因上游组蛋白乙酰化,导致顺式作用现象,等位基因表达失衡。
英文摘要
(1) Development of conventional assay kit for the allelic expression ratio (AER) A single nucleotide polymorphism (SNP), T/T-deletion, position at 88742 in human CYP3A4 gene is used for the marker Serial dilution standard samples using DNAs (i e, homozygous for each allele) were used for the calibration Correlation between allelic ratio and fluorescence intensity (VIC / FAM) was excellent We developed conventional assay kit for AER in the CYP3A4 gene using TaqMan primers and probe sets.(2) Clinical Application Using this assay kit, we evaluated relationship between individual AER and metabolic activities of midazolam and itraconazole in Japanese healthy volunteers Unfortunately, due to the small sample sizes, clear relationships were not observed Since individual AER was estimated successfully, a larger sample size study using more specific substrate drugs for CYP3A4 is warranted.(3) Methylation analysis There are various CpG islands in the imprinting control center (ICR), ICR is located on the upstream of human CYP3A4 gene When we focused on 4 CG sites at position 82363 to 82893, methylation frequencies at 14th and 16th CG sites negatively correlated with the CYP3A4 m RNA expression levels at significantly.(4) Histone acetylation 5'-upstream and 3'-downstream regions, 5'-UTR, and promoter regions of the CYP3A4 gene were selected as targets Large interindividual differences in the anti-Ac-H3 binding capacity were observed in various target regions, histone acetylation in 5'-upstream regions of CYP3A4 was significantly correlated with mRNA expression.(5) Methylation status and Histone acetylation Methylation frequencies in above mentioned 4 CG sites were significantly correlated with histone acetylation at approximately 2000 bp upstream of the CYP3A4 gene These results suggest that DNA methylation in the ICR involved in the histone acetylation at the upstream of the CYP3A4 gene, leading to cis-acting phenomenon, allelic expression imbalance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rifampin reduces the analgesic effect of transdermal fentanyl.
利福平降低透皮芬太尼的镇痛作用。
DOI: --
发表时间: 2005
期刊: The annals of Pharmacotherapy 39
影响因子: --
作者: [Takane, H., Nosaka, A., Wakushima, H., Hosokawa, K, Ieiri I et al.]
通讯作者: Ieiri I et al.
DOI: --
发表时间: 2008
期刊: Curr Drug Metab 9
影响因子: --
作者: [Hirota, T., Takane, H., Higuchi, S]
通讯作者: S
分子薬物動態学
分子药代动力学
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [Kayoko Ohura, Teruko Imai, 今井輝子, 今井輝子, 今井輝子, 今井 輝子, 今井輝子, 今井輝子, Teruko Imai, 今井輝子, 今井輝子]
通讯作者: 今井輝子
Ieiri I : Rifampin reduces the analgesic effect of transdermal fentanyl
Ieiri I :利福平降低透皮芬太尼的镇痛效果
DOI: --
发表时间: 2005
期刊: Ann Pharmacother 39
影响因子: --
作者: [Takane, H., Nosaka, A., Wakushima, H., Hosokawa, K]
通讯作者: K
共 12 条
    The role of miR-27a in regulation of P-gp expression
    • 批准号:
      25670078
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      IEIRI Ichiro
    • 依托单位:
    Cohesin-dependentregulation of the expression of drug transporter genes
    • 批准号:
      23659083
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2010
    • 负责人:
      IEIRI Ichiro
    • 依托单位:
    Investigation of clinical impacts of CNV in the pharmacokinetic-related genes
    • 批准号:
      20390048
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2008
    • 负责人:
      IEIRI Ichiro
    • 依托单位:
    In vivo functional characterization of the ABC transporters based on the genetic polymorphisms
    • 批准号:
      13357020
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $23.38万
    • 财政年份:
      2001
    • 负责人:
      IEIRI Ichiro
    • 依托单位:
    国内基金
    海外基金
    CYP3A5介导的索拉非尼肝细胞癌耐药及其DNA甲基化调控机制研究
    • 批准号:
      LQ23H310003
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      汪佳琪
    • 依托单位:
    CYP3A5功能新解: 抑制肺腺癌侵袭转移及分子机制
    • 批准号:
      81472702
    • 项目类别:
      面上项目
    • 资助金额:
      64.0万元
    • 批准年份:
      2014
    • 负责人:
      蒋峰
    • 依托单位:
    PBPK建模预测CYP3A5基因型对五酯胶囊和他克莫司药动相互作用的影响
    • 批准号:
      81473409
    • 项目类别:
      面上项目
    • 资助金额:
      68.0万元
    • 批准年份:
      2014
    • 负责人:
      相小强
    • 依托单位:
    异基因造血干细胞移植患者CYP3A4、CYP3A5和MDR1基因多态性影响环孢素个体化用药的定量研究
    • 批准号:
      81141039
    • 项目类别:
      专项基金项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2011
    • 负责人:
      姜德春
    • 依托单位: